Aspire-Lakewood Holdings, Inc. (ASBP)
Nasdaq · Consumer Cyclical · Auto Parts
$8.88+1.14%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $12.4M
- 52-week range
- $0.11 – $18.76
- 52-week change
- −42.99%
- EPS (trailing)
- −$30.89
Fiscal year to Dec 2025
- Revenue
- $6K
- Net income
- −$24.5M
- Operating margin
- −312012.3%
- Diluted EPS
- −$16.38
From the company’s annual report on SEC EDGAR.
About Aspire-Lakewood Holdings, Inc.
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects. Its lead prescription product candidate, Sublingual High Dose Aspirin, targets pain management and anti-inflammatory applications. The company also develops Alprazolam in a sublingual formulation for anxiety treatment and offers Buzz Bomb Caffeine, a sublingually administered caffeine pre-workout consumer supplement. Additionally, it develops sublingual formulations of Melatonin for sleep aid, Sublingual ED for erectile dysfunction, testosterone products, and vitamins D, E, and K. The company targets therapeutic applications including heart attack and stroke, anxiety, antiplatelet conditions, nausea, pain management, and inflammation.
Headquarters: Estero, United States · aspirelakewoodholdings.com